These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 29309296

  • 1. High-grade Endometrioid Carcinoma of the Ovary: A Clinicopathologic Study of 30 Cases.
    Assem H, Rambau PF, Lee S, Ogilvie T, Sienko A, Kelemen LE, Köbel M.
    Am J Surg Pathol; 2018 Apr; 42(4):534-544. PubMed ID: 29309296
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
    Rambau PF, McIntyre JB, Taylor J, Lee S, Ogilvie T, Sienko A, Morris D, Duggan MA, McCluggage WG, Köbel M.
    Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.
    Madore J, Ren F, Filali-Mouhim A, Sanchez L, Köbel M, Tonin PN, Huntsman D, Provencher DM, Mes-Masson AM.
    J Pathol; 2010 Feb; 220(3):392-400. PubMed ID: 19967725
    [Abstract] [Full Text] [Related]

  • 5. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
    Hoang LN, McConechy MK, Köbel M, Han G, Rouzbahman M, Davidson B, Irving J, Ali RH, Leung S, McAlpine JN, Oliva E, Nucci MR, Soslow RA, Huntsman DG, Gilks CB, Lee CH.
    Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
    [Abstract] [Full Text] [Related]

  • 6. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
    Chui MH, Ryan P, Radigan J, Ferguson SE, Pollett A, Aronson M, Semotiuk K, Holter S, Sy K, Kwon JS, Soma A, Singh N, Gallinger S, Shaw P, Arseneau J, Foulkes WD, Gilks CB, Clarke BA.
    Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA, Wethington SL, Cesari M, Chiappetta D, Olvera N, Shia J, Levine DA.
    Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
    Zhao C, Bratthauer GL, Barner R, Vang R.
    Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
    [Abstract] [Full Text] [Related]

  • 9. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
    Sieh W, Köbel M, Longacre TA, Bowtell DD, deFazio A, Goodman MT, Høgdall E, Deen S, Wentzensen N, Moysich KB, Brenton JD, Clarke BA, Menon U, Gilks CB, Kim A, Madore J, Fereday S, George J, Galletta L, Lurie G, Wilkens LR, Carney ME, Thompson PJ, Matsuno RK, Kjær SK, Jensen A, Høgdall C, Kalli KR, Fridley BL, Keeney GL, Vierkant RA, Cunningham JM, Brinton LA, Yang HP, Sherman ME, García-Closas M, Lissowska J, Odunsi K, Morrison C, Lele S, Bshara W, Sucheston L, Jimenez-Linan M, Driver K, Alsop J, Mack M, McGuire V, Rothstein JH, Rosen BP, Bernardini MQ, Mackay H, Oza A, Wozniak EL, Benjamin E, Gentry-Maharaj A, Gayther SA, Tinker AV, Prentice LM, Chow C, Anglesio MS, Johnatty SE, Chenevix-Trench G, Whittemore AS, Pharoah PD, Goode EL, Huntsman DG, Ramus SJ.
    Lancet Oncol; 2013 Aug; 14(9):853-62. PubMed ID: 23845225
    [Abstract] [Full Text] [Related]

  • 10. Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation.
    Ussakli C, Usubutun A, Dincer N, Dolgun A, Bülbül D, Isikdogan Z, Haberal N, Ozen O, Tezel GG.
    Pol J Pathol; 2016 Aug; 67(3):221-227. PubMed ID: 28155970
    [Abstract] [Full Text] [Related]

  • 11. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.
    Hu S, Hinson JL, Matnani R, Cibull ML, Karabakhtsian RG.
    Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium.
    Egan JA, Ionescu MC, Eapen E, Jones JG, Marshall DS.
    Int J Gynecol Pathol; 2004 Apr; 23(2):119-22. PubMed ID: 15084839
    [Abstract] [Full Text] [Related]

  • 13. The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
    Hussein YR, Broaddus R, Weigelt B, Levine DA, Soslow RA.
    Int J Gynecol Pathol; 2016 Jan; 35(1):16-24. PubMed ID: 26166718
    [Abstract] [Full Text] [Related]

  • 14. Endometrioid Carcinoma of the Ovary: Outcomes Compared to Serous Carcinoma After 10 Years of Follow-Up.
    Bouchard-Fortier G, Panzarella T, Rosen B, Chapman W, Gien LT.
    J Obstet Gynaecol Can; 2017 Jan; 39(1):34-41. PubMed ID: 28062021
    [Abstract] [Full Text] [Related]

  • 15. Transitional cell-like morphology in ovarian endometrioid carcinoma: morphologic, immunohistochemical, and behavioral features distinguishing it from high-grade serous carcinoma.
    Karnezis AN, Aysal A, Zaloudek CJ, Rabban JT.
    Am J Surg Pathol; 2013 Jan; 37(1):24-37. PubMed ID: 23108017
    [Abstract] [Full Text] [Related]

  • 16. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
    Rekhi B, Deodhar KK, Menon S, Maheshwari A, Bajpai J, Ghosh J, Shylasree ST, Gupta S.
    APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
    [Abstract] [Full Text] [Related]

  • 17. Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon.
    Boyd C, McCluggage WG.
    Am J Surg Pathol; 2012 Mar; 36(3):368-75. PubMed ID: 22082603
    [Abstract] [Full Text] [Related]

  • 18. Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.
    Mackenzie R, Talhouk A, Eshragh S, Lau S, Cheung D, Chow C, Le N, Cook LS, Wilkinson N, McDermott J, Singh N, Kommoss F, Pfisterer J, Huntsman DG, Köbel M, Kommoss S, Gilks CB, Anglesio MS.
    Am J Surg Pathol; 2015 Nov; 39(11):1548-57. PubMed ID: 26099008
    [Abstract] [Full Text] [Related]

  • 19. Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
    Morency E, Leitao MM, Soslow RA.
    Int J Gynecol Pathol; 2016 May; 35(3):222-9. PubMed ID: 26630225
    [Abstract] [Full Text] [Related]

  • 20. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I, D'Angelo E, Corominas M, Gonzalez A, Prat J.
    Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.